Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score

Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacogenomics 2020-11, Vol.21 (16), p.1151-1156
Hauptverfasser: Gilani, Syed SA, Nair, Nisha, Plant, Darren, Hyrich, Kimme, Morgan, Ann W, Morris, Andrew P, Wilson, Anthony G, Isaacs, John D, Barton, Anne, Bluett, James
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1156
container_issue 16
container_start_page 1151
container_title Pharmacogenomics
container_volume 21
creator Gilani, Syed SA
Nair, Nisha
Plant, Darren
Hyrich, Kimme
Morgan, Ann W
Morris, Andrew P
Wilson, Anthony G
Isaacs, John D
Barton, Anne
Bluett, James
description
doi_str_mv 10.2217/pgs-2020-0043
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_2217_pgs_2020_0043</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_2217_pgs_2020_0043</sourcerecordid><originalsourceid>FETCH-LOGICAL-c823-40aa9e1a0ddfc6b036b181bf1c665799478ce54fca9a539919d94d775a1d8d2c3</originalsourceid><addsrcrecordid>eNot0EtOwzAABFALgUQpLNn7AgbbcZx4WZVfpUogCOvI8acxauzKNkXlGFyAu3ESEsFqZjOzeABcEnxFKamud5uEKKYYYcyKIzAjFWOoxowej51xiigj_BScpfSGMSWc4RnYP_UyDlKFjfEmO5VgsLDxFq587zqXQ_z5_jJpF3wy0Hn43Jv3QebgNFzE3EeXXYKv2W3dp_MbmHsDm4-AlmEYJ8ZneOOSkeN2obLbu3yALypEcw5OrNwmc_Gfc9Dc3TbLB7R-vF8tF2ukaloghqUUhkistVW8wwXvSE06SxTnZSUEq2plSmaVFLIshCBCC6arqpRE15qqYg7Q362KIaVobLuLbpDx0BLcTmbtaNZOZu1kVvwCXN1jUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score</title><source>PubMed Central</source><creator>Gilani, Syed SA ; Nair, Nisha ; Plant, Darren ; Hyrich, Kimme ; Morgan, Ann W ; Morris, Andrew P ; Wilson, Anthony G ; Isaacs, John D ; Barton, Anne ; Bluett, James</creator><creatorcontrib>Gilani, Syed SA ; Nair, Nisha ; Plant, Darren ; Hyrich, Kimme ; Morgan, Ann W ; Morris, Andrew P ; Wilson, Anthony G ; Isaacs, John D ; Barton, Anne ; Bluett, James ; BRAGGSS Consortium</creatorcontrib><identifier>ISSN: 1462-2416</identifier><identifier>EISSN: 1744-8042</identifier><identifier>DOI: 10.2217/pgs-2020-0043</identifier><language>eng</language><ispartof>Pharmacogenomics, 2020-11, Vol.21 (16), p.1151-1156</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c823-40aa9e1a0ddfc6b036b181bf1c665799478ce54fca9a539919d94d775a1d8d2c3</citedby><cites>FETCH-LOGICAL-c823-40aa9e1a0ddfc6b036b181bf1c665799478ce54fca9a539919d94d775a1d8d2c3</cites><orcidid>0000-0003-3316-2527 ; 0000-0003-1395-9344 ; 0000-0003-1109-624X ; 0000-0001-5062-5779 ; 0000-0002-6103-7056 ; 0000-0002-6805-6014 ; 0000-0001-8242-9262 ; 0000-0003-1188-6778 ; 0000-0001-9829-792X ; 0000-0003-4855-3926</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Gilani, Syed SA</creatorcontrib><creatorcontrib>Nair, Nisha</creatorcontrib><creatorcontrib>Plant, Darren</creatorcontrib><creatorcontrib>Hyrich, Kimme</creatorcontrib><creatorcontrib>Morgan, Ann W</creatorcontrib><creatorcontrib>Morris, Andrew P</creatorcontrib><creatorcontrib>Wilson, Anthony G</creatorcontrib><creatorcontrib>Isaacs, John D</creatorcontrib><creatorcontrib>Barton, Anne</creatorcontrib><creatorcontrib>Bluett, James</creatorcontrib><creatorcontrib>BRAGGSS Consortium</creatorcontrib><title>Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score</title><title>Pharmacogenomics</title><issn>1462-2416</issn><issn>1744-8042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNot0EtOwzAABFALgUQpLNn7AgbbcZx4WZVfpUogCOvI8acxauzKNkXlGFyAu3ESEsFqZjOzeABcEnxFKamud5uEKKYYYcyKIzAjFWOoxowej51xiigj_BScpfSGMSWc4RnYP_UyDlKFjfEmO5VgsLDxFq587zqXQ_z5_jJpF3wy0Hn43Jv3QebgNFzE3EeXXYKv2W3dp_MbmHsDm4-AlmEYJ8ZneOOSkeN2obLbu3yALypEcw5OrNwmc_Gfc9Dc3TbLB7R-vF8tF2ukaloghqUUhkistVW8wwXvSE06SxTnZSUEq2plSmaVFLIshCBCC6arqpRE15qqYg7Q362KIaVobLuLbpDx0BLcTmbtaNZOZu1kVvwCXN1jUg</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Gilani, Syed SA</creator><creator>Nair, Nisha</creator><creator>Plant, Darren</creator><creator>Hyrich, Kimme</creator><creator>Morgan, Ann W</creator><creator>Morris, Andrew P</creator><creator>Wilson, Anthony G</creator><creator>Isaacs, John D</creator><creator>Barton, Anne</creator><creator>Bluett, James</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-3316-2527</orcidid><orcidid>https://orcid.org/0000-0003-1395-9344</orcidid><orcidid>https://orcid.org/0000-0003-1109-624X</orcidid><orcidid>https://orcid.org/0000-0001-5062-5779</orcidid><orcidid>https://orcid.org/0000-0002-6103-7056</orcidid><orcidid>https://orcid.org/0000-0002-6805-6014</orcidid><orcidid>https://orcid.org/0000-0001-8242-9262</orcidid><orcidid>https://orcid.org/0000-0003-1188-6778</orcidid><orcidid>https://orcid.org/0000-0001-9829-792X</orcidid><orcidid>https://orcid.org/0000-0003-4855-3926</orcidid></search><sort><creationdate>202011</creationdate><title>Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score</title><author>Gilani, Syed SA ; Nair, Nisha ; Plant, Darren ; Hyrich, Kimme ; Morgan, Ann W ; Morris, Andrew P ; Wilson, Anthony G ; Isaacs, John D ; Barton, Anne ; Bluett, James</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c823-40aa9e1a0ddfc6b036b181bf1c665799478ce54fca9a539919d94d775a1d8d2c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilani, Syed SA</creatorcontrib><creatorcontrib>Nair, Nisha</creatorcontrib><creatorcontrib>Plant, Darren</creatorcontrib><creatorcontrib>Hyrich, Kimme</creatorcontrib><creatorcontrib>Morgan, Ann W</creatorcontrib><creatorcontrib>Morris, Andrew P</creatorcontrib><creatorcontrib>Wilson, Anthony G</creatorcontrib><creatorcontrib>Isaacs, John D</creatorcontrib><creatorcontrib>Barton, Anne</creatorcontrib><creatorcontrib>Bluett, James</creatorcontrib><creatorcontrib>BRAGGSS Consortium</creatorcontrib><collection>CrossRef</collection><jtitle>Pharmacogenomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilani, Syed SA</au><au>Nair, Nisha</au><au>Plant, Darren</au><au>Hyrich, Kimme</au><au>Morgan, Ann W</au><au>Morris, Andrew P</au><au>Wilson, Anthony G</au><au>Isaacs, John D</au><au>Barton, Anne</au><au>Bluett, James</au><aucorp>BRAGGSS Consortium</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score</atitle><jtitle>Pharmacogenomics</jtitle><date>2020-11</date><risdate>2020</risdate><volume>21</volume><issue>16</issue><spage>1151</spage><epage>1156</epage><pages>1151-1156</pages><issn>1462-2416</issn><eissn>1744-8042</eissn><doi>10.2217/pgs-2020-0043</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-3316-2527</orcidid><orcidid>https://orcid.org/0000-0003-1395-9344</orcidid><orcidid>https://orcid.org/0000-0003-1109-624X</orcidid><orcidid>https://orcid.org/0000-0001-5062-5779</orcidid><orcidid>https://orcid.org/0000-0002-6103-7056</orcidid><orcidid>https://orcid.org/0000-0002-6805-6014</orcidid><orcidid>https://orcid.org/0000-0001-8242-9262</orcidid><orcidid>https://orcid.org/0000-0003-1188-6778</orcidid><orcidid>https://orcid.org/0000-0001-9829-792X</orcidid><orcidid>https://orcid.org/0000-0003-4855-3926</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1462-2416
ispartof Pharmacogenomics, 2020-11, Vol.21 (16), p.1151-1156
issn 1462-2416
1744-8042
language eng
recordid cdi_crossref_primary_10_2217_pgs_2020_0043
source PubMed Central
title Pharmacogenetics of Tnf Inhibitor⟒esponse in Rheumatoid Arthritis Utilizing the Two-Component Disease Activity Score
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A18%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacogenetics%20of%20Tnf%20Inhibitor%E2%9F%92esponse%20in%20Rheumatoid%20Arthritis%20Utilizing%20the%20Two-Component%20Disease%20Activity%20Score&rft.jtitle=Pharmacogenomics&rft.au=Gilani,%20Syed%20SA&rft.aucorp=BRAGGSS%20Consortium&rft.date=2020-11&rft.volume=21&rft.issue=16&rft.spage=1151&rft.epage=1156&rft.pages=1151-1156&rft.issn=1462-2416&rft.eissn=1744-8042&rft_id=info:doi/10.2217/pgs-2020-0043&rft_dat=%3Ccrossref%3E10_2217_pgs_2020_0043%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true